Biomarin Pharmaceutical Inc Financial Flexibility Index
Biomarin Pharmaceutical Inc financial flexibility index. Biomarin Pharmaceutical Inc (BMRN) has a Financial Flexibility Index of 0.04x as of June 2026. Free cash flow of $196.93 Million (operating CF $168.11 Million minus capex $28.82 Million) represents 0% of total liabilities ($5.40 Billion). See BMRN FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Biomarin Pharmaceutical Inc (1998–2025)
Financial flexibility index of Biomarin Pharmaceutical Inc from 1998 to 2025. Historical Financial Flexibility Index trend for Biomarin Pharmaceutical Inc across 28 annual periods. Check Biomarin Pharmaceutical Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Biomarin Pharmaceutical Inc Financial Flexibility Index by Year (1998–2025)
Biomarin Pharmaceutical Inc financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Biomarin Pharmaceutical Inc. For the full cash flow conversion analysis, see Biomarin Pharmaceutical Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | $931.03 Million | $827.99 Million | $1.51 Billion | ▲ +22.7% |
| 2024 | 0.50x | $670.26 Million | $572.84 Million | $1.33 Billion | ▲ +256.7% |
| 2023 | 0.14x | $266.87 Million | $159.26 Million | $1.89 Billion | ▼ -15.7% |
| 2022 | 0.17x | $296.86 Million | $175.90 Million | $1.77 Billion | ▼ -31.5% |
| 2021 | 0.24x | $423.76 Million | $304.54 Million | $1.73 Billion | ▲ +91.2% |
| 2020 | 0.13x | $222.88 Million | $85.36 Million | $1.74 Billion | ▲ +3.8% |
| 2019 | 0.12x | $193.29 Million | $48.26 Million | $1.57 Billion | ▲ +9.2% |
| 2018 | 0.11x | $164.83 Million | $20.21 Million | $1.46 Billion | ▲ +8.2% |
| 2017 | 0.10x | $190.46 Million | $-8.76 Million | $1.82 Billion | ▲ +265.2% |
| 2016 | -0.06x | $-79.46 Million | $-227.84 Million | $1.26 Billion | ▼ -1507.6% |
| 2015 | 0.00x | $5.96 Million | $-221.69 Million | $1.33 Billion | ▼ -90.5% |
| 2014 | 0.05x | $45.30 Million | $-73.54 Million | $962.56 Million | ▲ +674.0% |
| 2013 | 0.01x | $5.49 Million | $-59.63 Million | $903.02 Million | ▼ -94.6% |
| 2012 | 0.11x | $62.18 Million | $17.61 Million | $552.58 Million | ▼ -65.3% |
| 2011 | 0.32x | $172.97 Million | $18.75 Million | $532.66 Million | ▲ +159.6% |
| 2010 | 0.13x | $68.21 Million | $18.75 Million | $545.37 Million | ▼ -58.1% |
| 2009 | 0.30x | $177.53 Million | $87.73 Million | $594.98 Million | ▲ +298.3% |
| 2008 | 0.07x | $47.19 Million | $-9.18 Million | $630.02 Million | ▲ +489.1% |
| 2007 | -0.02x | $-12.08 Million | $-34.49 Million | $627.55 Million | ▲ +73.9% |
| 2006 | -0.07x | $-25.51 Million | $-50.09 Million | $345.63 Million | ▲ +66.3% |
| 2005 | -0.22x | $-59.72 Million | $-62.68 Million | $272.76 Million | ▼ -60.5% |
| 2004 | -0.14x | $-41.07 Million | $-65.14 Million | $300.94 Million | ▲ +72.5% |
| 2003 | -0.50x | $-68.82 Million | $-74.80 Million | $138.49 Million | ▲ +87.7% |
| 2002 | -4.04x | $-48.73 Million | $-53.59 Million | $12.07 Million | ▼ -842.3% |
| 2001 | -0.43x | $-5.25 Million | $-23.07 Million | $12.26 Million | ▲ +67.5% |
| 2000 | -1.32x | $-9.14 Million | $-12.90 Million | $6.94 Million | ▼ -168.1% |
| 1999 | 1.93x | $10.00 Million | $-12.94 Million | $5.17 Million | ▲ +340.1% |
| 1998 | -0.81x | $-1.70 Million | $-8.10 Million | $2.11 Million | — |